Results 91 to 100 of about 14,484 (178)

Correction: A Framework for Using Cost‑effectiveness Analysis to Support Pricing and Reimbursement Decisions for New Pharmaceuticals in a Context of Evolving Treatments, Prices, and Evidence. [PDF]

Pharmacoeconomics
Woods B, Palacios A, Sculpher M.
europepmc   +1 more source

A new way to read the price: measuring global affordability of selected NOACs. [PDF]

Front Pharmacol
Cynar J, Cavaco AM, Nowakowska E, Kus K, Ratajczak P, Zaprutko T.   +5 more
europepmc   +1 more source

Comments on "Early health economic analysis of virtual reality therapy for pain management after surgery". [PDF]

Int J Surg
Pezeshkian A.
europepmc   +1 more source

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma. [PDF]

Pharmacoeconomics
Scholte M, Fernández Coves A, Yang H, Armstrong N, McDermott K, Tian X, Stirk L, Wolff R, Joore MA, Grimm SE.   +9 more
europepmc   +1 more source

Flexibility in the Modelling of Comparative Effectiveness in the Absence of Head-to-Head Comparisons in the NICE Single Technology Appraisal of Fenfluramine for Treating Seizures Associated with Lennox-Gastaut Syndrome: An External Assessment Group Perspective. [PDF]

Pharmacoeconomics
Fernández Coves A, Scholte M, Wolff R, Perry M, Sugden B, Chen J, Armstrong N, Joore M, Witlox W.   +8 more
europepmc   +1 more source

Editorial: Advances in the potential treatments of gastrointestinal and liver diseases: addressing the public health burden, volume II. [PDF]

Front Pharmacol
Turcu-Stiolica A, Dimitrova M, Jinga M.
europepmc   +1 more source

Implications of Medicare Negotiation and Most-Favored-Nation Pricing for Cancer Medicine Costs.

JAMA Health Forum
Hwang TJ, Tibau A, Kesselheim AS, Vokinger KN.   +3 more
europepmc   +1 more source

Cost-effectiveness of hypofractionated radiation therapy versus conventional radiation therapy for unresectable stage III non-small cell lung cancer. [PDF]

Sci Rep
Zhang H, Liu Y, Zeng G, Hu S, Li H, Wang H.   +5 more
europepmc   +1 more source

Awareness and Sociodemographic Factors as Predictors of Knowledge About Health Economics and Pharmacoeconomics Among Registered Nurses: A Cross-Sectional Study. [PDF]

Clinicoecon Outcomes Res
Alanazi HI, Tumala RB, Asiri MY, Alharbi HA, Alenazy BA, Al-Ghareeb SA, Alsmari AA, Alsbaie MA.   +7 more
europepmc   +1 more source

Maximizing public health benefits: Policy perspectives on coverage and cell-based influenza vaccines in the US. [PDF]

Hum Vaccin Immunother
Nguyen VH, Mould-Quevedo JF.
europepmc   +1 more source